000 | 01592 a2200433 4500 | ||
---|---|---|---|
005 | 20250513204120.0 | ||
264 | 0 | _c20000412 | |
008 | 200004s 0 0 eng d | ||
022 | _a1040-8428 | ||
024 | 7 |
_a10.1016/s1040-8428(99)00042-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeonard, R C | |
245 | 0 | 0 |
_aIdarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer. _h[electronic resource] |
260 |
_bCritical reviews in oncology/hematology _cJan 2000 |
||
300 |
_a61-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Congress; Multicenter Study | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aFatigue _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
650 | 0 | 4 |
_aInfections _xchemically induced |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
700 | 1 | _aCameron, D A | |
700 | 1 | _aAnderson, A | |
700 | 1 | _aOstrowski, J | |
700 | 1 | _aHowell, A | |
773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 33 _gno. 1 _gp. 61-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1040-8428(99)00042-6 _zAvailable from publisher's website |
999 |
_c10668874 _d10668874 |